Aortic Valve Market: Information by Valve Type
(Mechanical and Biological), Suture Type (Suture and Sutureless), Surgery Type
(Minimally Invasive Surgery (Transfemoral, Transaortic Implantation,
Transapical, and Trans-subclavian) and Open surgery), End-User (Hospitals,
Ambulatory Surgery Centers) and Region (Americas, Europe, Asia-Pacific, and the
Middle East & Africa) - Forecast till 2025
Market
Highlights
According
to MRFR analysis, Aortic Valve Market is expected to register a CAGR
of 11.1% during the forecast period of 2019 to 2025 and held a value
of USD 6,454.91 Million in 2018.
An aortic
valve is surgically implanted in the heart to replace a valve that has damaged
due to heart valve diseases such as stenosis, regurgitation, and atresia. The
replacement of damaged valves with prosthetic heart valves reduces the
morbidity and mortality associated with aortic valve disorders.
The
growth of the global aortic valve market is boosted by various factors such as
the rising geriatric population, surge in prevalence of cardiac disorders, in
conjunction with the introduction of innovative products in the market.
According to the Heart Valve Voice, approximately 1.5 million people over the
age of 65 years are currently affected by heart valve disease in the UK, and
the number is expected to increase up to 19 million by 2050. Moreover,
increasing product approvals are likely to provide favorable conditions for the
growth of the market. For instance, in June 2017, the US FDA granted market
clearance for aortic and mitral valve-in-valve procedures using the Edwards
Lifesciences Sapien 3 transcatheter heart valve (THV).
However,
product recalls due to safety reasons and changing regulatory landscapes are
likely to hamper the growth of the market during the forecast period.
Several
market players currently dominate the global aortic valve market. The key
players are engaged in product launches and strategic collaborations to
strengthen their market positions.
Regional
Analysis
The
market has been divided, by region, into the Americas, Europe, Asia-Pacific,
and the Middle East & Africa. The Americas held the maximum share in the
base year 2018, owing to the presence of established key players in countries
such as the US and Canada. The aortic valve market in the Americas has further
been branched into North America and Latin America, with the North American
market is further divided into the US and Canada. The European aortic valve
market has been categorized as Western Europe and Eastern Europe. The Western
European market has been classified as Germany, France, the UK, Italy, Spain,
and the rest of Western Europe. The aortic valve market in Asia-Pacific has
been segmented into Japan, China, India, South Korea, Australia, and the rest
of Asia-Pacific. The aortic valve market in this region is anticipated to be
the fastest growing during the assessment period due to the booming geriatric
population, rising prevalence of cardiovascular diseases, and favorable
government initiatives for disease treatment. The aortic valve market in the
Middle East & Africa has been divided into the Middle East and Africa.
Aortic
Valve Market Segmentation
The
Global Aortic Valve Market has been segmented based on Type of Valve, Suture,
Surgery, and End User.
The
market, based on valve type, has been divided into mechanical and biological.
The mechanical valve segment is likely to be the largest due to the high
adoption of mechanical valves in replacement procedures. The biological valves
segment is predicted to be the fastest-growing due to the increasing awareness
about the advantages of biological valves in replacement procedures. Magna Ease
(Edwards Lifesciences Corporation), Hancock II
(Medtronic), Trifecta (Abbott) are some of the well-known biological valves’
brands currently present in the market.
The Global Aortic Valve Market has been segmented, based on the surgery type, into minimally invasive surgery and open surgery. The
minimally invasive surgery segment is further divided into transfemoral,
transaortic implantation, transapical, and trans-subclavian. It is expected to
hold majority share of the market owing to shorter hospital stay, less pain,
and faster recovery as compared to open-heart surgery.
The end users of the market are hospitals, ambulatory
surgery centers. The hospital segment is likely to hold the maximum share
during the forecast period.
Key Players
Some of the key players in the Global Aortic Valve Market are Boston
Scientific Corporation (US), Medtronic(US), Abbott Laboratories (US), LivaNova
PLC (UK), Edwards Lifesciences Corporation (US), CryoLife (US), Biotronik
(Germany), Colibri Heart Valve (US), JenaValve (US), and TTK HealthCare
(India), among others.
No comments:
Post a Comment